Vikas Sehdev, Ph.D., B.Pharm.

Assistant Director of Research
Associate Professor of Pharmaceutical and Administrative Sciences
Email Dr. Sehdev
Office: 222


  • Assistant Professor and Program Advisor (Pharmacology & Toxicology Graduate Program), Division of Pharmaceutical Sciences, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY, USA, (2013 – 2017).
  • Postdoctoral Research Fellow, Upper Gastrointestinal Cancer Biology and Therapeutics, Department of Surgical Oncology & Research, Vanderbilt University Medical Center, TN, USA, (2009 -2013).
  • Ph.D., Pharmaceutical Sciences (Cancer Biology), Department of Biomedical Research & Pharmaceutical Sciences, College of Pharmacy, Idaho State University, ID, USA, (2004 – 2009).
  • B.Pharm., Pharmacy, College of Pharmacy, M.J.P Rohilkhand University, Uttar Pradesh, India, (1999 – 2003).

Teaches in:

  • PHRM 6109 Principles of Pathophysiology II
  • PHRM 6110 Principles of Pharmacology/Medicinal Chemistry II
  • PHRM 7111 MTM VIII – Endocrine/Reproductive
  • PHRM 7112 Neurosensory
Research interests include:

Cancer Biology, Drug Discovery and Drug Development: Primary areas of interest include identification and characterization of novel therapeutic targets, investigational anticancer agents, and synergistic drug combinations for the treatment of Breast, Blood, and Gastrointestinal Cancers.

Selected Publications:

1. T. Dichwalkar, S. Bapat, P. Pancholi, N. Jasani, B. Desai, V. K. Yellepeddi & Vikas Sehdev “Omega-3 fatty acid grafted PAMAM-Paclitaxel conjugate exhibits enhanced anticancer activity in Upper Gastrointestinal Cancer cells” (Macromolecular Bioscience, 2017 May 9., doi: 10.1002/mabi.201600457. [Epub ahead of print]).
2. S. Keshisyan, Vikas Sehdev, J. Gray & S. Ray “Cytostatic agents” (Book Chapter: Side Effects of Drugs Annual Volume 37, Nov. 2015, Chapter 44, Pages 567-581, Edited by Sidhartha D. Ray, ISBN: 978-0-444-63525-9).
3. J. Betzu, N. Jasani, B. Desai & Vikas Sehdev “Selective targeting of M3 muscarinic receptors: An opportunity for improved treatment of Upper Gastrointestinal Carcinomas” (Pharmacy & Pharmacology International Journal, 2014 Nov. 03, 1(1): 00001).
4. Vikas Sehdev, A. Dar, W. El-Rifai, “Aurora kinases in Cancer: An opportunity for Targeted Therapy”. (Book Chapter: Molecular Oncology: Causes of Cancer & Targets for Treatment. Edited by Gelmann, Sawyers & Rauscher III., Dec. 2013, Chapter 23, Pages 278-292, ISBN: 9780521876629).
5. Vikas Sehdev, A. Katsha, D. Peng et al., “HDM2 Regulation by AURKA Promotes Cell Survival in Gastric Cancer”. (Clinical Cancer Research, 2014 Jan 1;20(1)).


Fun Fact:

I am passionate about teaching and research. I enjoy working with students and I like to make judicious use of technology in class.